Episode #14 - These hamsters have birthed billions for biotech
The Chinese hamster has led a secret life in science for decades. By one estimate, 11 biotech drugs that are made using Chinese hamster ovar...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Signal
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promi...
Episodes
10 episodes
Episode #13 - The superbugs are quietly amassing their forces -- and we're helping them
A deadly new superbug is just starting to surface worldwide. Who is to blame for its rise? Well, us, really. Public health officials are war...
Episode #12 - Before you pop that Tylenol, listen to this podcast
How confident are you that the drugs you take, whether they're over-the-counter or prescription, are totally understood by the companies who...
Episode #11 - Sexism in biotech, from scantily clad models to how gender affects this podcast
In this episode of Signal, we take on a subject that might make some of our listeners feel uncomfortable — but more importantly, it should m...
Episode #10 - Cancer is a low-down, dirty gangster ninja
Cancer plays dirty. Like a gangster. That's how it wins. Over the past few years, scientists have been learning its tricks and tactics. They...
Episode #9 - What should you most fear? Sharks, killer snails or the flu?
How do our perceptions of risk, and our outsized — or undersized — fears affect our health? In this episode of Signal we explore the killer...
SIgnal takes a mini-break for a special reason
Hi, Signal listeners, we have some happy news to share — Meg is getting married! That means we’ll be taking a break for a few weeks, but fea...
Episode #6 - Choosing scientific sides in the fight against Alzheimer's
Alzheimer’s disease poses a huge threat to our health and our economy — more than 5 million Americans are estimated to currently have the di...
UPDATE: What happened at the FDA panel review of one Duchenne drug?
An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal pod...
Hello, World! It's Signal.
An introduction to Signal, a podcast from Stat. (Image: Fox Photos/Getty Images)